×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NASDAQ:ISRG

Intuitive Surgical Price Target, Predictions & Analyst Ratings

$206.10
+5.39 (+2.69%)
(As of 07/1/2022 03:59 PM ET)
Add
Compare
Today's Range
$200.01
$206.36
50-Day Range
$190.71
$246.31
52-Week Range
$186.83
$369.69
Volume
76,468 shs
Average Volume
1.98 million shs
Market Capitalization
$73.98 billion
P/E Ratio
45.83
Dividend Yield
N/A
Price Target
$323.24

Intuitive Surgical (NASDAQ:ISRG) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 19 Analyst Ratings

Consensus Analyst Price Target

$323.24
56.84% Upside
High Prediction$363.33
Average Prediction$323.24
Low Prediction$225.00
TypeCurrent
7/5/21 to 7/5/22
1 Month Ago
6/5/21 to 6/5/22
3 Months Ago
4/6/21 to 4/6/22
1 Year Ago
7/5/20 to 7/5/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
11 Buy rating(s)
9 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$323.24$327.41$331.31$268.10
Predicted Upside56.84% Upside13.81% Upside12.04% Upside5.14% Upside
Get Intuitive Surgical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.


ISRG Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ISRG Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Intuitive Surgical Stock vs. The Competition

TypeIntuitive SurgicalMedical CompaniesS&P 500
Consensus Rating Score
2.74
2.72
2.51
Consensus RatingModerate BuyBuyBuy
Predicted Upside56.84% Upside475.37% Upside31.66% Upside
News Sentiment RatingPositive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
969
72.10%
Underperform Votes
375
27.90%
Avg. Outperform Votes
166
66.94%
Avg. Underperform Votes
82
33.06%
Avg. Outperform Votes
839
69.11%
Avg. Underperform Votes
375
30.89%

Historical Intuitive Surgical Price Targets and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/22/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$300.00 ➝ $225.00+15.79%
6/3/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Adam Maeder
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$316.00+45.09%
5/17/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$360.00 ➝ $305.00+38.93%
4/25/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$325.00 ➝ $300.00+18.22%
4/22/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$350.00 ➝ $339.00+15.08%
4/22/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$294.00 ➝ $280.00-4.95%
4/22/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$334.00 ➝ $330.00+12.03%
4/12/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$360.00+29.57%
4/5/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoveragePeer Perform$315.00+6.45%
3/25/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$340.00+20.96%
3/1/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy ➝ Buy
2/2/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matthew Taylor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$317.00 ➝ $325.00+13.43%
1/25/2022Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
1/21/2022BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$372.00 ➝ $360.00+32.65%
1/21/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$370.00 ➝ $325.00+11.02%
1/21/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$370.00 ➝ $315.00+7.61%
12/16/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeBuy ➝ Conviction-Buy
8/26/2021SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$325.00 ➝ $346.67-0.38%
7/21/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$300.00 ➝ $333.33+6.60%
4/21/2021Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform
9/28/2020Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$258.33+15.03%
7/20/2020Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lee Hambright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$208.33 ➝ $241.67+11.41%
6/16/2020OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradePositive
4/17/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Sell
1/10/2020Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Craig Bijou
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight$206.67 ➝ $230.00+17.79%
10/18/2019Piper Jaffray Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
JP McKim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetBuy$211.00+11.79%
7/19/2019Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Suraj Kalia
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetSell$125.00-30.27%
(Data available from 7/5/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Intuitive Surgical Price Target - Frequently Asked Questions

What is Intuitive Surgical's consensus rating and price target?

According to the issued ratings of 19 analysts in the last year, the consensus rating for Intuitive Surgical stock is Moderate Buy based on the current 6 hold ratings, 12 buy ratings and 1 strong buy rating for ISRG. The average twelve-month price prediction for Intuitive Surgical is $323.24 with a high price target of $363.33 and a low price target of $225.00. Learn more on ISRG's analyst rating history.

Do Wall Street analysts like Intuitive Surgical more than its competitors?

Analysts like Intuitive Surgical stock more than the stock of other Medical companies. The consensus rating for Intuitive Surgical is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how ISRG compares to other companies.

Do MarketBeat users like Intuitive Surgical more than its competitors?

MarketBeat users like Intuitive Surgical stock more than the stock of other Medical companies. 72.10% of MarketBeat users gave Intuitive Surgical an outperform vote while medical companies recieve an average of 66.94% outperform votes by MarketBeat users.

Does Intuitive Surgical's stock price have much upside?

According to analysts, Intuitive Surgical's stock has a predicted upside of 14.67% based on their 12-month price targets.

What analysts cover Intuitive Surgical?
This page (NASDAQ:ISRG) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.